Dario Priem

6PUBLICATIONS
7CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Synchrotrons and accelerators not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 01, 2025
TAB2 controls a TAK1-independent cell death checkpoint at the level of TNFR1 complex II in the TNF pathway.

Tom Delanghe, Mike Vadi, Annelore Haems

|Nov 19, 2023
NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis.

Yves Dondelinger, Dario Priem, Jon Huyghe

|Apr 04, 2023
LC3-independent autophagy is vital to prevent TNF cytotoxicity.

Dario Priem, Jon Huyghe, Mathieu Jm Bertrand

|Dec 15, 2022
ATG9A prevents TNF cytotoxicity by an unconventional lysosomal targeting pathway.

Jon Huyghe, Dario Priem, Lisette Van Hove

|Jul 15, 2021
Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor.

Tom Delanghe, Jon Huyghe, Seungheon Lee

Pageof 1